Extracellular-Vesicle-Associated UBE2NL and HIST2H3PS2 Promote Tumor Aggressiveness and Metastasis in Gynecologic Cancer
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26104833 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Chih-Ming Ho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Cathay General Hospital, Taipei 106, Taiwan. Hauptthemen laut MEDLINE: Extracellular Vesicles, Ubiquitin-Conjugating Enzymes, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Council, Taiwan.
Abstract (Originalsprache)
Extracellular vesicles (EVs) play pivotal roles in tumor progression and metastasis by mediating intercellular communication within the tumor microenvironment. In this study, we identified two novel EX cargo proteins—UBE2NL and HIST2H3PS2—derived from highly aggressive epithelial ovarian cancer (EOC) cells and mesenchymal-type ovarian stromal progenitor cells (MSC-OCSPCs) but absent in less aggressive SKOV3 cells. Quantitative proteomic profiling via LC-MS/MS and TCGA-integrated analysis revealed that high expression of these genes correlated with advanced tumor stages and poor overall survival in EOC, and high HIST2H3PS2 expression predicted poor survival in endometrial cancer (EC). Functionally, UBE2NL and HIST2H3PS2 overexpression promoted EOC cell invasiveness, which was further enhanced by EX-mediated autocrine and paracrine effects. In contrast, the knockdown of UBE2NL reduced cell invasiveness and prolonged mouse survival in vivo. Moreover, HIST2H3PS2-enriched EXs significantly increased peritoneal dissemination and ascites in murine models. These findings suggest that EX-packaged UBE2NL and HIST2H3PS2 drive tumor aggressiveness and metastasis in gynecologic cancers, highlighting their potential as prognostic biomarkers and therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Cathay General Hospital, Taipei 106, Taiwan.
- School of Medicine, Fu Jen Catholic University, Hsinchuang, New Taipei City 242, Taiwan.
- Department of Medical Research, Cathay General Hospital, Sijhih, New Taipei City 221, Taiwan.
- School of Medicine, Taipei Medical University, Taipei 110, Taiwan.
- Graduate Institute of Biomedical Informatics, Taipei Medical University, Taipei 110, Taiwan.
- Department of Pathology, Cathay General Hospital, Taipei 106, Taiwan.
ORCID-Profile: Chih-Ming Ho, Ting-Lin Yen, Tzu-Hao Chang
Förderung
- National Science Council, Taiwan
Zitieren
APA
Ho, C. M., Yen, T. L., Chang, T. H., & Huang, S. H. (2025). Extracellular-Vesicle-Associated UBE2NL and HIST2H3PS2 Promote Tumor Aggressiveness and Metastasis in Gynecologic Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104833
Vancouver
Ho CM, Yen TL, Chang TH, Huang SH. Extracellular-Vesicle-Associated UBE2NL and HIST2H3PS2 Promote Tumor Aggressiveness and Metastasis in Gynecologic Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104833
BibTeX
@article{Ho2025,
author = {Ho, Chih-Ming and Yen, Ting-Lin and Chang, Tzu-Hao and Huang, Shih-Hung},
title = {Extracellular-Vesicle-Associated UBE2NL and HIST2H3PS2 Promote Tumor Aggressiveness and Metastasis in Gynecologic Cancer},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26104833}
}
EUVIMED